Опухоли головы и шеи. 2019; 9: 77-82
Солитарный метастаз светлоклеточного варианта почечно-клеточного рака в щитовидной железе
https://doi.org/10.17650/2222-1468-2019-9-3-77-82Аннотация
Представлен клинический случай солитарного метастаза светлоклеточного варианта почечно-клеточного рака в щитовидной железе. Первоначально считалось, что новообразование щитовидной железы имеет доброкачественный характер: при обследовании были выявлены признаки, характерные для этого вида патологии. После операции на щитовидной железе иммуногистохимическое исследование тканей удаленной опухоли позволило верифицировать диагноз.
Список литературы
1. Chung A.Y., Tran T.B., Brumund K.T. et al. Metastases to the thyroid: a review of the literature from the last decade. Thyroid 2012;22(3):258–68. DOI: 10.1089/thy.2010.0154.
2. Кригер А.Г., Паклина О.В., Кочатков А.В. и др. Метастазы почечно-клеточного рака в поджелудочную железу. Хирургия. Журнал им. Н.И. Пирогова 2012;(9):26–31.
3. Leva J. Zur Lehre qes Morbus Addissonii. Arch Part Anat 1891;125(1):35–74.
4. Пинский С.Б., Калинин А.П., Белобородов В.А., Дворниченко В.В. Редкие опухоли и заболевания щитовидной железы. Иркутск, 1999. 208 с.
5. Bianchi M., Sun M., Jeldres C. et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 2012;23(4):973–80. DOI: 10.1093/annonc/mdr362.
6. Kobayashi K., Hirokawa M., Yabuta T. et al. Metastatic carcinoma to the thyroid gland from renal cell carcinoma: role of ultrasonography in preoperative diagnosis. Thyroid Res 2015;8:4. DOI: 10.1186/s13044-015-0016-4.
7. Song O., Koo J.S., Kwak J.Y. et al. Metastatic renal cell carcinoma in the thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsy. Ultrasonography 2017;36(3):252–9. DOI: 10.14366/usg.16037.
8. Rizzo M., Rossi R.T., Bonaffini O. et al. Thyroid metastasis of clear cell renal carcinoma: report of a case. Diagn Cytopathol 2009;37(10):759–62. DOI: 10.1002/dc.21117.
9. Iesalnieks I., Machens A., Bures C. et al. Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma. Ann Surg Oncol 2015;22(6):1798–805. DOI: 10.1245/s10434-014-4266-5.
10. Motzer R.J., Bacik J., Schwartz L.H. et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004;22(3):454–63. DOI: 10.1200/JCO.2004.06.132.
11. Vogl U., Zehetgruber H., Dominkus M. et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer 2006;95(6):691–8. DOI: 10.1038/sj.bjc.6603327.
12. Gravis G., Chanez B., Derosa L. et al. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era. Urol Oncol 2016;34(4):167.e17–23. DOI: 10.1016/j.urolonc.2015.10.015.
13. Bedke J., Gauler T., Grünwald V. et al. Systemic therapy in metastatic renal cell carcinoma. World J Urol 2017;35(2):179–88. DOI: 10.1007/s00345-016-1868-5.
14. Thomas A.Z., Adibi M., Borregales L.D. et al. Cytoreductive surgery in the era of targeted molecular therapy. Transl Androl Urol 2015;4(3):301–9. DOI: 10.3978/j.issn.2223-4683.2015.04.09.
15. Abel E.J., Wood C.G. Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy. Nat Rev Urol 2009;6(7):375–83. DOI: 10.1038/nrurol.2009.102.
16. Dabestani S., Marconi L., Hofmann F. еt al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 2014;15(12):e549–61. DOI: 10.1016/S1470-2045(14)70235-9.
17. Weiti H., Chevalley J. Coitres jaune safran. Metastases dans la thyroide des hypernefromes. Pres Med 1966;74(50):2595–8.
18. Horowitz J.J., Fajardo M., Callahan L.D., Yang R. Clear cell carcinoma of the thyroid. Int Surg 1966;45(4):429–39.
19. Yamauchi M., Kai K., Shibamiya N. et al. Didactic surgical experience of thyroid metastasis from renal cell carcinoma: a case report. World J Clin Cases 2018;6(15):1018–23. DOI: 10.12998/wjcc.v6.i15.1018.
Head and Neck Tumors (HNT). 2019; 9: 77-82
Solitary metastasis of the clear cell variant of renal cell carcinoma into the thyroid gland
https://doi.org/10.17650/2222-1468-2019-9-3-77-82Abstract
Clinical case of solitary metastasis of the clear cell variant of renal cell carcinoma into the thyroid gland was analyzed. The thyroid mass was initially considered to be benign. The diagnostic showed signs similar to thyroid follicular neoplasia. The patient was operated on. The thyroid tumor was finally diagnosed as metastasis from clear cell variant of renal cell carcinoma.
References
1. Chung A.Y., Tran T.B., Brumund K.T. et al. Metastases to the thyroid: a review of the literature from the last decade. Thyroid 2012;22(3):258–68. DOI: 10.1089/thy.2010.0154.
2. Kriger A.G., Paklina O.V., Kochatkov A.V. i dr. Metastazy pochechno-kletochnogo raka v podzheludochnuyu zhelezu. Khirurgiya. Zhurnal im. N.I. Pirogova 2012;(9):26–31.
3. Leva J. Zur Lehre qes Morbus Addissonii. Arch Part Anat 1891;125(1):35–74.
4. Pinskii S.B., Kalinin A.P., Beloborodov V.A., Dvornichenko V.V. Redkie opukholi i zabolevaniya shchitovidnoi zhelezy. Irkutsk, 1999. 208 s.
5. Bianchi M., Sun M., Jeldres C. et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 2012;23(4):973–80. DOI: 10.1093/annonc/mdr362.
6. Kobayashi K., Hirokawa M., Yabuta T. et al. Metastatic carcinoma to the thyroid gland from renal cell carcinoma: role of ultrasonography in preoperative diagnosis. Thyroid Res 2015;8:4. DOI: 10.1186/s13044-015-0016-4.
7. Song O., Koo J.S., Kwak J.Y. et al. Metastatic renal cell carcinoma in the thyroid gland: ultrasonographic features and the diagnostic role of core needle biopsy. Ultrasonography 2017;36(3):252–9. DOI: 10.14366/usg.16037.
8. Rizzo M., Rossi R.T., Bonaffini O. et al. Thyroid metastasis of clear cell renal carcinoma: report of a case. Diagn Cytopathol 2009;37(10):759–62. DOI: 10.1002/dc.21117.
9. Iesalnieks I., Machens A., Bures C. et al. Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma. Ann Surg Oncol 2015;22(6):1798–805. DOI: 10.1245/s10434-014-4266-5.
10. Motzer R.J., Bacik J., Schwartz L.H. et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004;22(3):454–63. DOI: 10.1200/JCO.2004.06.132.
11. Vogl U., Zehetgruber H., Dominkus M. et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer 2006;95(6):691–8. DOI: 10.1038/sj.bjc.6603327.
12. Gravis G., Chanez B., Derosa L. et al. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era. Urol Oncol 2016;34(4):167.e17–23. DOI: 10.1016/j.urolonc.2015.10.015.
13. Bedke J., Gauler T., Grünwald V. et al. Systemic therapy in metastatic renal cell carcinoma. World J Urol 2017;35(2):179–88. DOI: 10.1007/s00345-016-1868-5.
14. Thomas A.Z., Adibi M., Borregales L.D. et al. Cytoreductive surgery in the era of targeted molecular therapy. Transl Androl Urol 2015;4(3):301–9. DOI: 10.3978/j.issn.2223-4683.2015.04.09.
15. Abel E.J., Wood C.G. Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy. Nat Rev Urol 2009;6(7):375–83. DOI: 10.1038/nrurol.2009.102.
16. Dabestani S., Marconi L., Hofmann F. et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 2014;15(12):e549–61. DOI: 10.1016/S1470-2045(14)70235-9.
17. Weiti H., Chevalley J. Coitres jaune safran. Metastases dans la thyroide des hypernefromes. Pres Med 1966;74(50):2595–8.
18. Horowitz J.J., Fajardo M., Callahan L.D., Yang R. Clear cell carcinoma of the thyroid. Int Surg 1966;45(4):429–39.
19. Yamauchi M., Kai K., Shibamiya N. et al. Didactic surgical experience of thyroid metastasis from renal cell carcinoma: a case report. World J Clin Cases 2018;6(15):1018–23. DOI: 10.12998/wjcc.v6.i15.1018.
